Sign In

Sachin Kelkar

CFO at Purespring Therapeutics

Sachin Kelkar is the Chief Financial Officer at Purespring Therapeutics, a pioneering gene therapy company focused on transforming the treatment of kidney diseases.12 He joined Purespring in February 2023, bringing over 25 years of experience as a finance and strategy executive.23

Prior to joining Purespring, Sachin held several notable positions:

  1. Chief Financial Officer at Geltor Inc., a biodesign startup, where he built the finance and operations functions and raised significant venture financing.13
  2. Co-founder of LifeTech Capital, a boutique investment bank offering corporate finance advisory services to healthcare companies.1
  3. Director of Strategic Accounts at Yodlee, Inc., where he managed top client relationships with major financial institutions.1

Sachin's educational background includes:

  • Bachelor of Arts (B.A.) in Cell/Cellular and Molecular Biology from the University of California, Berkeley.1
  • MBA from the University of Chicago Booth School of Business.13

At Purespring Therapeutics, Sachin is part of the senior leadership team that is preparing the company's kidney gene therapy programmes for clinical development.23 His role involves bringing strength to finance and corporate development, supporting the company's strategic leadership.2

Highlights

Aug 8 · PR Web
Digital Health Startup FareWell Announces Key Hires as it Launches its Enterprise Offering Aimed at Reversing Chronic Disease in the Workplace - PR Web

Related Questions

What are Sachin Kelkar's key achievements at Geltor Inc?
How did Sachin Kelkar contribute to Yodlee's growth?
What strategies did Sachin Kelkar implement at LifeTech Capital?
What is Sachin Kelkar's educational background?
How has Sachin Kelkar's experience in corporate finance benefited Purespring Therapeutics?
Sachin Kelkar
Sachin Kelkar, photo 1
Sachin Kelkar, photo 2
Add to my network

Location

London, England, United Kingdom